您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical composition comprising a siRNA targeting VEGFA and method to decrease the expression of VEGFA in vivo.
专利权人:
ALCON RESEARCH LTD
发明人:
SMITH ANJA,REYNOLDS ANGELA,CHATTERTON JON E,ZHANG XINYU
申请号:
CL2013000237
公开号:
CL2013000237A1
申请日:
2013.01.24
申请国别(地区):
CL
年份:
2014
代理人:
摘要:
Vascular endothelial growth factor A (VEGFA) is a chemical signal produced by cells that stimulates the growth of new blood vessels, and overexpression of VEGFA can lead to undesirable physiological conditions. Through the identification of new siRNA and modifications that improve the silencing ability of these siRNA in vivo, therapeutic compositions and methods have been invented to address the problems associated with this overexpression.COMPOSICION FARMACEUTICA QUE COMPRENDE UN siRNA DIRIGIDO A VEGFA; Y METODO PARA DISMINUIR LA EXPRESION DE VEGFA IN VIVO.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充